Weight Loss & Metabolic

AOD-9604

hGH fragment 177-191 · Anti-Obesity Drug 9604

A modified fragment of human growth hormone (amino acids 177–191) targeting fat metabolism without affecting blood sugar.

Overview & Mechanism

Mimics the lipolytic (fat-burning) action of hGH without its effects on growth or insulin, stimulating the breakdown and oxidation of fat via beta-3 adrenergic pathways.

Research Dosage

Dose

250–500 mcg/day

Route

Subcutaneous injection

Frequency

Once daily

Cycle

12 weeks

Reconstitution & Storage

Reconstitution

Reconstitute a 5 mg vial with 2 mL of bacteriostatic water (2.5 mg/mL). Best on an empty stomach in the morning.

Storage

Lyophilized: −20 °C. Reconstituted: refrigerate 2–8 °C, use within 28–30 days.

Safety & Side Effects

Well tolerated in clinical studies; minimal reported side effects. Does not affect blood glucose or IGF-1.

Studies

AOD-9604 lipolysis and safety

AOD-9604 stimulated lipolysis and inhibited lipogenesis in vitro and in animals; human trials showed weight loss trends without significant adverse effects.

Read study

References

Research Use Only

This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.